Comparison
Semaglutide vs Tirzepatide
| Feature | Semaglutide | Tirzepatide |
|---|---|---|
| Mechanism | GLP-1 receptor agonist | Dual GIP/GLP-1 agonist |
| FDA approval | Ozempic, Wegovy, Rybelsus | Mounjaro, Zepbound |
| Weight loss (trials) | See evidence library | See evidence library |
| Administration | Weekly injection or daily oral | Weekly injection |
| CV outcome data | Yes (SELECT trial) | Ongoing trials |
Factual comparison only. No dosing information. Consult a qualified physician.
Looking for a physician who prescribes Semaglutide?
Find a ProviderOr see how peptide therapy near you works and request a referral.